Booster vaccination at 6-8 years of age with a reduced antigen content dTpa-IPV vaccine is immunogenic and safe after priming with whole-cell pertussis vaccine

Tzou Yien Lin, Ying Hsiang Wang, Yhu Chering Huang, Cheng Hsun Chiu, Yi Lin Pen, Haiwen Tang, Bernard Hoet, Hans L. Bock

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Pertussis vaccines containing reduced amounts of antigen have been considered primarily for use in adolescents and adults to date. We evaluated a reduced antigen content combined diphtheria tetanus acellular pertussis and inactivated polio vaccine (dTpa-IPV) in 6-8 year-old children in Taiwan, who had received four doses of DTPw (combined diphtheria, tetanus, whole cell pertussis vaccine) and OPV (oral polio vaccine). One month after the booster dose, seroprotection rates and vaccine response rates to all antigens were at least 98.8%, and significant increases in antibody concentrations were observed. Booster vaccination was associated with minor local reactions and systemic symptoms. Symptoms of severe intensity did not occur, with the exception of local pain. The dTpa-IPV vaccine was immunogenic and well tolerated in 6-8 year-old children and offers an alternative to the current use of tetanus and diphtheria vaccine and OPV in Taiwan, addressing the established need for repeated booster vaccinations against pertussis at the same time.

Original languageEnglish
Pages (from-to)50-53
Number of pages4
JournalHuman Vaccines
Volume4
Issue number1
Publication statusPublished - Jan 2008
Externally publishedYes

Fingerprint

Pertussis Vaccine
Inactivated Vaccines
Diphtheria
Whooping Cough
Tetanus
Poliomyelitis
Vaccination
Vaccines
Antigens
Taiwan
Diphtheria-Tetanus Vaccine
Pain
Antibodies

Keywords

  • Booster
  • Diphtheria
  • Pertussis
  • Tetanus
  • Vaccination

ASJC Scopus subject areas

  • Immunology
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Booster vaccination at 6-8 years of age with a reduced antigen content dTpa-IPV vaccine is immunogenic and safe after priming with whole-cell pertussis vaccine. / Lin, Tzou Yien; Wang, Ying Hsiang; Huang, Yhu Chering; Chiu, Cheng Hsun; Pen, Yi Lin; Tang, Haiwen; Hoet, Bernard; Bock, Hans L.

In: Human Vaccines, Vol. 4, No. 1, 01.2008, p. 50-53.

Research output: Contribution to journalArticle

Lin, Tzou Yien ; Wang, Ying Hsiang ; Huang, Yhu Chering ; Chiu, Cheng Hsun ; Pen, Yi Lin ; Tang, Haiwen ; Hoet, Bernard ; Bock, Hans L. / Booster vaccination at 6-8 years of age with a reduced antigen content dTpa-IPV vaccine is immunogenic and safe after priming with whole-cell pertussis vaccine. In: Human Vaccines. 2008 ; Vol. 4, No. 1. pp. 50-53.
@article{416d7d85eaf643efa1ff53caf5ddd7d7,
title = "Booster vaccination at 6-8 years of age with a reduced antigen content dTpa-IPV vaccine is immunogenic and safe after priming with whole-cell pertussis vaccine",
abstract = "Pertussis vaccines containing reduced amounts of antigen have been considered primarily for use in adolescents and adults to date. We evaluated a reduced antigen content combined diphtheria tetanus acellular pertussis and inactivated polio vaccine (dTpa-IPV) in 6-8 year-old children in Taiwan, who had received four doses of DTPw (combined diphtheria, tetanus, whole cell pertussis vaccine) and OPV (oral polio vaccine). One month after the booster dose, seroprotection rates and vaccine response rates to all antigens were at least 98.8{\%}, and significant increases in antibody concentrations were observed. Booster vaccination was associated with minor local reactions and systemic symptoms. Symptoms of severe intensity did not occur, with the exception of local pain. The dTpa-IPV vaccine was immunogenic and well tolerated in 6-8 year-old children and offers an alternative to the current use of tetanus and diphtheria vaccine and OPV in Taiwan, addressing the established need for repeated booster vaccinations against pertussis at the same time.",
keywords = "Booster, Diphtheria, Pertussis, Tetanus, Vaccination",
author = "Lin, {Tzou Yien} and Wang, {Ying Hsiang} and Huang, {Yhu Chering} and Chiu, {Cheng Hsun} and Pen, {Yi Lin} and Haiwen Tang and Bernard Hoet and Bock, {Hans L.}",
year = "2008",
month = "1",
language = "English",
volume = "4",
pages = "50--53",
journal = "Human Vaccines",
issn = "1554-8600",
publisher = "Landes Bioscience",
number = "1",

}

TY - JOUR

T1 - Booster vaccination at 6-8 years of age with a reduced antigen content dTpa-IPV vaccine is immunogenic and safe after priming with whole-cell pertussis vaccine

AU - Lin, Tzou Yien

AU - Wang, Ying Hsiang

AU - Huang, Yhu Chering

AU - Chiu, Cheng Hsun

AU - Pen, Yi Lin

AU - Tang, Haiwen

AU - Hoet, Bernard

AU - Bock, Hans L.

PY - 2008/1

Y1 - 2008/1

N2 - Pertussis vaccines containing reduced amounts of antigen have been considered primarily for use in adolescents and adults to date. We evaluated a reduced antigen content combined diphtheria tetanus acellular pertussis and inactivated polio vaccine (dTpa-IPV) in 6-8 year-old children in Taiwan, who had received four doses of DTPw (combined diphtheria, tetanus, whole cell pertussis vaccine) and OPV (oral polio vaccine). One month after the booster dose, seroprotection rates and vaccine response rates to all antigens were at least 98.8%, and significant increases in antibody concentrations were observed. Booster vaccination was associated with minor local reactions and systemic symptoms. Symptoms of severe intensity did not occur, with the exception of local pain. The dTpa-IPV vaccine was immunogenic and well tolerated in 6-8 year-old children and offers an alternative to the current use of tetanus and diphtheria vaccine and OPV in Taiwan, addressing the established need for repeated booster vaccinations against pertussis at the same time.

AB - Pertussis vaccines containing reduced amounts of antigen have been considered primarily for use in adolescents and adults to date. We evaluated a reduced antigen content combined diphtheria tetanus acellular pertussis and inactivated polio vaccine (dTpa-IPV) in 6-8 year-old children in Taiwan, who had received four doses of DTPw (combined diphtheria, tetanus, whole cell pertussis vaccine) and OPV (oral polio vaccine). One month after the booster dose, seroprotection rates and vaccine response rates to all antigens were at least 98.8%, and significant increases in antibody concentrations were observed. Booster vaccination was associated with minor local reactions and systemic symptoms. Symptoms of severe intensity did not occur, with the exception of local pain. The dTpa-IPV vaccine was immunogenic and well tolerated in 6-8 year-old children and offers an alternative to the current use of tetanus and diphtheria vaccine and OPV in Taiwan, addressing the established need for repeated booster vaccinations against pertussis at the same time.

KW - Booster

KW - Diphtheria

KW - Pertussis

KW - Tetanus

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=44649095664&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44649095664&partnerID=8YFLogxK

M3 - Article

C2 - 18376147

AN - SCOPUS:44649095664

VL - 4

SP - 50

EP - 53

JO - Human Vaccines

JF - Human Vaccines

SN - 1554-8600

IS - 1

ER -